CD20+ infiltrating B cells in the tumor nests were higher in positive PD-L1 tumors, whereas stromal CD20+ TILs showed a higher density in negative PD-L1 tumors (i.e., expression in less than 10% of tumor cells). The gene discussed is MS4A1; the disease is neoplasm.